TCL Archive NCS Group Asks DRG Adjustments For Institutions With Peer reviewed Components, 25 Protocol Patients July 1, 1983
TCL Archive Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial July 25, 2014
TCL Archive New Technology May Enable Therapy Tailored To Patient’s Predicted Response April 26, 2002
TCL Archive In Brief: Mayo Director Kovach Moves To City Of Hope; Seattle Institutions Win Gene Therapy May 20, 1994
